ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009

May 13, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2009-05-12

Reporting Person: Clendeninn Neil James (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-05-12	stock option (right to buy)	$7.25	A	8260	Acquired	2016-05-12	Common Stock (8260)	Direct

Footnotes

F1: 2.065 options are exercisable on each of August 12, 2009, November 12, 2009, February 12, 2010 and May 12, 2010.